Back to Pathstone Holdings, LLC Pathstone Holdings, LLC

ABOSABOS
Showing 8 of 11 quarters

Position history for Pathstone Holdings, LLCPathstone Holdings, LLC's holdings in ACUMEN PHARMACEUTICALS INC

Pathstone Holdings, LLC holds 859,110 shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $2.3M as of 2026-Q2. ABOS represents 0.0% of Pathstone Holdings, LLC's portfolio.

Current Value

$2.3M

Current Shares

859,110

Total Value Change

+$1M

Total Shares Change

+341,827

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
859,110
0.0%
$2.3M0.0%$2.67
0
2026-Q1
Unchanged
859,110
0.0%
$2M0.0%$3.31
0
2025-Q4
Unchanged
859,110
0.0%
$1.8M0.0%$2.00
0
2025-Q3
Decreased
859,110
-18.8%
$1.5M0.0%$1.58
0
2025-Q2
Decreased
1.1M
-2.6%
$1.2M0.0%$1.12
0
2025-Q1
Increased
1.1M
+79.0%
$1.2M0.0%$1.19
39
2024-Q4
Increased
606,845
+17.3%
$1M0.0%$1.75
29
2024-Q3
Increased
517,283
+7.7%
$1.3M0.0%$2.48
27

Other major holders of ABOS: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used